APA Corporation Announces Updates to Executive Leadership
HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) — APA Corporation (Nasdaq: APA) has announced updates to its executive leadership team to […]
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting
Highly selective oral SMARCA2 degrader, PRT7732, shows robust anti-tumor activity in vivo as monotherapy and in combination with chemotherapy, at […]
Applied Digital Reschedules Fiscal Third Quarter 2024 Earnings Conference Call to Thursday, April 11, 2024 at 5:00 p.m. Eastern Time
DALLAS, April 09, 2024 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”), a designer, builder […]
Vicor Corporation to Hold First Quarter Earnings Conference Call and Webcast on April 23, 2024
ANDOVER, Mass., April 09, 2024 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: VICR) announced today it will hold its first quarter […]
Jianzhi Education Technology Group Company Limited Reports Fiscal Year 2023 Financial Results
BEIJING, April 09, 2024 (GLOBE NEWSWIRE) — Jianzhi Education Technology Group Company Limited (the “Company” or “Jianzhi”) (NASDAQ: JZ), a […]
Veritex Holdings, Inc. Announces Dates of First Quarter 2024 Earnings Release and Conference Call
DALLAS, April 09, 2024 (GLOBE NEWSWIRE) — Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or “the Company”), the parent holding company […]
ChampionX Announces First Quarter 2024 Earnings Release Date
THE WOODLANDS, Texas, April 09, 2024 (GLOBE NEWSWIRE) — ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today that […]
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
– Preclinical data supports potential for proprietary nsCAR platform to selectively eliminate cancer cells while preserving healthy tissue – Gamma-delta […]
Dentsply Sirona to Host First Quarter Conference Call on May 2nd
CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) — DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced […]
TSX News -
Medicenna Presents Updated Results of Single Agent MDNA11 Anti-tumor Activity from Dose Escalation and Ongoing Dose Expansion of the Phase 1/2 ABILITY-1 Study at the 2024 Annual Meeting of the American Association for Cancer Research (AACR)
100% reduction of target lesions in one melanoma and one pancreatic cancer patient observed among 4 Partial Responses (PR) to […]
